A NON-INTERVENTIONAL STUDY ON AVELUMAB USE IN PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CARCINOMA

NCT04822350 · clinicaltrials.gov ↗

COMPLETED

Status

596

Enrollment

INDUSTRY

Sponsor class

Conditions

Urothelial Carcinoma

Interventions

DRUG: Avelumab

Sponsor

Pfizer

Collaborators

[object Object]